1. Home
  2. PDEX vs MOLN Comparison

PDEX vs MOLN Comparison

Compare PDEX & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDEX
  • MOLN
  • Stock Information
  • Founded
  • PDEX 1978
  • MOLN 2004
  • Country
  • PDEX United States
  • MOLN Switzerland
  • Employees
  • PDEX N/A
  • MOLN N/A
  • Industry
  • PDEX Medical/Dental Instruments
  • MOLN
  • Sector
  • PDEX Health Care
  • MOLN
  • Exchange
  • PDEX Nasdaq
  • MOLN Nasdaq
  • Market Cap
  • PDEX 167.6M
  • MOLN 136.1M
  • IPO Year
  • PDEX N/A
  • MOLN 2021
  • Fundamental
  • Price
  • PDEX $43.59
  • MOLN $3.71
  • Analyst Decision
  • PDEX Strong Buy
  • MOLN
  • Analyst Count
  • PDEX 1
  • MOLN 0
  • Target Price
  • PDEX $56.00
  • MOLN N/A
  • AVG Volume (30 Days)
  • PDEX 64.8K
  • MOLN 2.4K
  • Earning Date
  • PDEX 05-01-2025
  • MOLN 08-25-2025
  • Dividend Yield
  • PDEX N/A
  • MOLN N/A
  • EPS Growth
  • PDEX 379.10
  • MOLN N/A
  • EPS
  • PDEX 2.76
  • MOLN N/A
  • Revenue
  • PDEX $64,123,999.00
  • MOLN $2,525,030.00
  • Revenue This Year
  • PDEX $26.92
  • MOLN N/A
  • Revenue Next Year
  • PDEX $4.48
  • MOLN $866.67
  • P/E Ratio
  • PDEX $15.70
  • MOLN N/A
  • Revenue Growth
  • PDEX 29.65
  • MOLN N/A
  • 52 Week Low
  • PDEX $16.84
  • MOLN $3.36
  • 52 Week High
  • PDEX $70.26
  • MOLN $12.22
  • Technical
  • Relative Strength Index (RSI)
  • PDEX 50.59
  • MOLN 51.23
  • Support Level
  • PDEX $40.49
  • MOLN $3.58
  • Resistance Level
  • PDEX $45.86
  • MOLN $3.86
  • Average True Range (ATR)
  • PDEX 2.08
  • MOLN 0.16
  • MACD
  • PDEX 0.63
  • MOLN 0.01
  • Stochastic Oscillator
  • PDEX 60.88
  • MOLN 50.79

About PDEX Pro-Dex Inc.

Pro-Dex Inc is engaged in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. Majority of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: